Pathology Doctors in Winter Haven, FL Accepting Medicare

7 Pathology doctors found. Showing 1 - 7

Vera Volnikh, MD Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 1021 Jim Keene Blvd, Winter Haven, FL 33880 Phone: 863-298-4600

Phillip C. Gordon, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Avenue F Ne, Dept. Of Pathology, Winter Haven, FL 33881 Phone: 863-293-1121    Fax: 863-291-6071

Manhua C Sun, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Avenue F Ne, Dept. Of Pathology, Winter Haven, FL 33881 Phone: 863-293-1121    Fax: 863-291-6071

Stephen John Nelson, M.D. Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 1021 Jim Keene Blvd, District 10 Medical Examiner, Winter Haven, FL 33880 Phone: 863-298-4600    Fax: 863-298-5264

Larry D. Botz, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Avenue F Ne, Dept. Of Pathology, Winter Haven, FL 33881 Phone: 863-293-1121    Fax: 863-291-6071

Margaret Ann Evans, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Avenue F Ne, Dept. Of Pathology, Winter Haven, FL 33881 Phone: 863-293-1121    Fax: 863-291-6071

Jess Baker, D.O. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Avenue F Ne, Winter Haven, FL 33881 Phone: 863-293-1121

News Archive

High Throughput ChIP-seq Assay for Genome-wide Protein-DNA Analysis

Chromatrap®, a business unit of Porvair Sciences, has published a new application note that describes how Chromatrap® ChIP-seq assays now enable unbiased, genome-wide understanding of protein-DNA regulatory networks...

FDA approves J&JPRD's PANCREAZE NDA

Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.

Florida Governor proposes $70B budget; includes $132M in cuts to Medicaid

Florida Gov. Charlie Crist (R) on Thursday unveiled a $70 billion state budget for fiscal year 2009 that would reduce spending on health care by $132 million and that includes new initiatives to expand health coverage, the Orlando Sentinel reports (Kennedy/Deslatte, Orlando Sentinel, 2/1). Crist proposed reducing Medicaid reimbursements for HMOs by $60 million (Follick, Sarasota Herald-Tribune, 2/1).

Researchers to develop a safer and synthetic alternative to current heparin

With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.

Many discarded donor kidneys could be used for transplantation

When researchers examined information on pairs of kidneys from the same donor in which 1 kidney was used but the other was discarded, the kidneys that were used tended to perform well even though they were similar in quality to their partner kidneys that were not used.

Read more Medical News

› Verified 6 days ago